Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial-Reference-Cited by-同舟云学术

Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial

Published:2016-11 Issue:5 Volume:151 Page:893-901.e1
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Lawitz Eric,Reau Nancy,Hinestrosa Federico,Rabinovitz Mordechai,Schiff Eugene,Sheikh Aasim,Younes Ziad,Herring Robert,Reddy K. Rajender,Tran Tram,Bennett Michael,Nahass Ronald,Yang Jenny C.,Lu Sophia,Dvory-Sobol Hadas^ORCID,Stamm Luisa M.,Brainard Diana M.,McHutchison John G.,Pearlman Brian,Shiffman Mitchell,Hawkins Trevor,Curry Michael,Jacobson Ira

Funder

Gilead Sciences

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference21 articles.

1. World Health Organization. Hepatitis C: fact sheet number 164. Available from: http://www.who.int/mediacentre/factsheets/fs164/en/. Accessed: March 3, 2016.

2. Global distribution and prevalence of hepatitis C virus genotypes;Messina;Hepatology,2015

3. Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives;Asselah;Liver Int,2016

4. Safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy;Banerjee;Aliment Pharmacol Ther,2016

5. Current and evolving treatments of genotype 1 hepatitis C virus;Alqahtani;Gastroenterol Clin North Am,2015

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus;Current Medicinal Chemistry;2023-10-19

2. Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study;The Korean Journal of Internal Medicine;2023-07-01

3. The impact of sofosbuvir/velpatasvir/voxilaprevir treatment on serum hyperglycemia in hepatitis C virus infections: a systematic review and meta-analysis;Annals of Medicine;2023-01-19

4. Real World Efficacy and Safety of Sofosbuvir + Velpatasvir + Voxilaprevir in Romanian Patients with Genotype 1b HCV Infection Non-reponders to DAAs Therapy;Journal of Gastrointestinal and Liver Diseases;2022-12-17

5. Viral proteases as therapeutic targets;Molecular Aspects of Medicine;2022-12